Sarepta's (SRPT) DMD drug may be reviewed by FDA panel in January - Bloomberg

October 14, 2015 11:41 AM

Sarepta Therapeutics (NASDAQ: SRPT) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found